Futura Medical plc
FUM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £14 | £3 | £0 | £0 |
| % Growth | 349.1% | – | – | – |
| Cost of Goods Sold | £4 | £1 | £0 | £0 |
| Gross Profit | £10 | £2 | -£0 | -£0 |
| % Margin | 68.7% | 57.2% | – | – |
| R&D Expenses | £2 | £2 | £4 | £4 |
| G&A Expenses | £7 | £7 | £3 | £2 |
| SG&A Expenses | £7 | £7 | £3 | £2 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £8 | £9 | £7 | £6 |
| Operating Income | £1 | -£7 | -£7 | -£6 |
| % Margin | 8.4% | -224.6% | – | – |
| Other Income/Exp. Net | £0 | £0 | £0 | £0 |
| Pre-Tax Income | £1 | -£7 | -£7 | -£6 |
| Tax Expense | -£0 | -£0 | -£1 | -£1 |
| Net Income | £1 | -£7 | -£6 | -£5 |
| % Margin | 9.3% | -210% | – | – |
| EPS | 0.004 | -0.022 | -0.02 | -0.018 |
| % Growth | 119.9% | -6.4% | -10.9% | – |
| EPS Diluted | 0.004 | -0.022 | -0.02 | -0.018 |
| Weighted Avg Shares Out | 302 | 301 | 287 | 271 |
| Weighted Avg Shares Out Dil | 311 | 301 | 287 | 271 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | £1 | -£7 | -£7 | -£6 |
| % Margin | 10.1% | -220.4% | – | – |